The purpose of this study is to determine whether a daily prenatal supplement of iron plus folic acid or a daily prenatal supplement with multiple vitamins and minerals given to women from their first prenatal visit through delivery reduces perinatal mortality compared with a daily prenatal supplement of folic acid alone.
In the project area in China, the rate of perinatal mortality (stillbirths and infant deaths within 6 days of birth) is two times that of the United States. Causes of perinatal mortality include, but are not limited to, low birth weight and preterm delivery. Anemia (low hemoglobin) among pregnant women is associated with low birth weight and preterm delivery and also is elevated in the project area. Supplements of iron, folic acid, and other vitamins and minerals can prevent anemia among pregnant women, but the effects of these supplements on other maternal and infant health outcomes are unclear. Since 1993, the People's Republic of China has recommended that newly married women, and those who plan pregnancy, take 400μg of folic acid daily through the first trimester of pregnancy. Although WHO recommends that pregnant women take iron and folic acid supplements, there is currently no national recommendation that pregnant women in China take iron or other vitamin or mineral supplements (other than folic acid). UNICEF is now testing a prenatal vitamin and mineral supplement in programs to prevent low birth weight. Our study will provide additional information about the health impact of the UNICEF prenatal supplement versus an iron and folic acid supplement versus folic acid alone. Comparisons: * Infants of women who receive daily prenatal supplements that contain 400μg folic acid alone, will be compared with infants of women who receive daily supplements that contain 30 mg iron and 400 μg folic acid. * Infants of women who receive daily supplements that contain 30 mg iron and 400 μg folic acid will be compared with infants of women who receive a daily supplement containing 30 mg iron, 400μg folic acid and other vitamins and minerals (UNICEF formulation).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
18,962
pills by mouth, one per day, from the first prenatal visit until delivery, 400 micrograms (mcg) folic acid
pills by mouth, one per day, from the first prenatal visit until delivery, 400 mcg folic acid, 30 mg Fe
pills, one per day, from the first prenatal visit until delivery; folic acid 400 mcg, Fe 30 mg, vitamin(vit) A 800 mcg, vit E 10 mg, vit D 5 mcg, vit C 70 mg, vit B1 1.4 mg, vit B2 1.4 mg, vit B6 1.9 mg, vit B12 2.6 mcg, Niacin 18 mg, Zn 15 mg, Cu 2mg, Iodine 150 mcg, Selenium 65 mcg
Fengrun Maternal and Child Health Institute
Fengrun, Hebei, China
Yuanshi Maternal and Child Health Institute
Huaiyang, Hebei, China
Laoting Maternal and Child Health Institute
Laoting, Hebei, China
Mancheng Maternal and Child Health Institute
Mancheng, Hebei, China
Perinatal mortality, i.e., the number of stillbirths (fetal deaths of 28 weeks or more of gestation) and the number of deaths within the first 0-6 days of life per 1000 births (live births and stillbirths)
Time frame: 20 weeks gestation to 6 days postpartum
Maternal anemia
Time frame: 24-28 weeks gestation
Maternal anemia
Time frame: 4-8 weeks postpartum
Infant gestational age at birth, preterm delivery
Time frame: delivery
Infant birth weight, low birth weight
Time frame: at birth
Infant low weight-for-height
Time frame: infant age 6 months and 12 months
Infant anemia
Time frame: 6 months and 12 months of age
maternal gastrointestinal side effects
Time frame: monthly from a month after enrollment until delivery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Xianghe Maternal and Child Health Institute
Xianghe, Hebei, China